AI-assisted, human-published
01/28/2026 /Funding Events
TRex Bio Secures $50 Million in Oversubscribed Financing Round
TRex Bio successfully concludes an oversubscribed $50 million financing round with new and existing investors, focusing on precision immunoregulatory medicines and novel therapeutic targets.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com